# A Randomized Controlled Trial on Malaria Primaquine Treatment in Timika, Indonesia (TRIPI)

> **NCT02787070** · PHASE4 · COMPLETED · sponsor: **Menzies School of Health Research** · enrollment: 420 (actual)

## Conditions studied

- Uncomplicated Malaria

## Interventions

- **DRUG:** PQ supervised
- **DRUG:** PQ unsupervised

## Key facts

- **NCT ID:** NCT02787070
- **Lead sponsor:** Menzies School of Health Research
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09-14
- **Primary completion:** 2018-11
- **Final completion:** 2018-11
- **Target enrollment:** 420 (ACTUAL)
- **Last updated:** 2019-04-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02787070

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02787070, "A Randomized Controlled Trial on Malaria Primaquine Treatment in Timika, Indonesia (TRIPI)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02787070. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*